14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.58 $5.85 Friday, 3rd May 2024 CTMX stock ended at $4.43. This is 1.56% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 14.22% from a day low at $4.43 to a day high of $5.06.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Jul 24, 2020 $7.70 $7.93 $7.57 $7.76 558 366
Jul 23, 2020 $8.05 $8.20 $7.83 $7.92 281 243
Jul 22, 2020 $8.26 $8.36 $7.98 $8.06 318 000
Jul 21, 2020 $8.65 $8.65 $8.25 $8.29 333 800
Jul 20, 2020 $8.63 $8.75 $8.49 $8.57 208 300
Jul 17, 2020 $8.49 $8.68 $8.43 $8.62 241 100
Jul 16, 2020 $8.76 $8.76 $8.46 $8.51 365 800
Jul 15, 2020 $8.75 $9.15 $8.65 $8.83 562 800
Jul 14, 2020 $8.64 $8.65 $8.22 $8.55 687 900
Jul 13, 2020 $8.57 $9.29 $8.51 $8.69 583 000
Jul 10, 2020 $8.30 $8.77 $8.29 $8.52 404 700
Jul 09, 2020 $8.33 $8.48 $8.18 $8.31 265 800
Jul 08, 2020 $8.28 $8.50 $8.14 $8.38 310 100
Jul 07, 2020 $8.15 $8.46 $8.06 $8.23 351 900
Jul 06, 2020 $8.55 $8.55 $8.12 $8.20 396 000
Jul 02, 2020 $8.60 $8.67 $8.38 $8.41 449 157
Jul 01, 2020 $8.37 $8.59 $8.26 $8.52 344 572
Jun 30, 2020 $8.24 $8.36 $8.14 $8.33 678 194
Jun 29, 2020 $8.28 $8.53 $8.03 $8.21 381 059
Jun 26, 2020 $8.47 $8.72 $8.16 $8.20 735 047
Jun 25, 2020 $8.24 $8.73 $8.21 $8.56 360 731
Jun 24, 2020 $8.62 $8.70 $8.17 $8.30 405 253
Jun 23, 2020 $8.65 $9.09 $8.65 $8.76 542 064
Jun 22, 2020 $8.27 $8.65 $7.98 $8.57 592 906
Jun 19, 2020 $8.53 $8.68 $8.25 $8.25 2 922 388
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT